Navigation Links
Soligenix Forms Consortium to Develop Thermostable Technology to Advance RiVax(TM) and Other Rapidly Acting Vaccines
Date:11/20/2009

PRINCETON, N.J., Nov. 20 /PRNewswire-FirstCall/ -- Soligenix, Inc. (OTC Bulletin Board: SNGX) (Soligenix or the Company), formerly known as DOR BioPharma, Inc., a late-stage biotechnology company, announced today that it has formed a consortium to develop thermostable technology to advance RiVax(TM) and other rapidly acting vaccines. Soligenix received a $9.4 million grant from the National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), to support this work.

A key component of this initiative is the formation of collaborative partnerships between industry and academic researchers from different disciplines. Soligenix will partner with academic institutions, including the University of Colorado, the University of Kansas, and the Tulane National Primate Research Center. Industry partners include SRI International, Health Research Inc, Battelle Memorial Institute, Nanotherapeutics, and BioCon Inc.

As part of the initiative, Soligenix has executed an option agreement with the University of Colorado. The agreement covers novel technology to develop vaccines that can maintain stability at elevated temperatures. This new technology will form the cornerstone of the R&D effort. Work will involve the development of formulation and manufacturing processes for vaccines, including RiVax(TM), that are stable at elevated temperatures. An additional goal will be the development of improved thermostable adjuvants expected to result in rapidly acting vaccines that can be given with fewer injections over shorter intervals.

"Each of our academic and industry consortium members brings impressive expertise to our vaccine stabilization program," said Dr. Robert N. Brey, PhD, Chief Scientific Officer of Soligenix. "This association has the potential to address the practical issue of long-term stability in stockpiled biodefense vaccines, using a technology basis that can ultim
'/>"/>

SOURCE Soligenix, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Rules-Based Medicine Forms Biomarker Alliance With Covance Inc.
2. CareFusion Launches Knowledge Portal to Provide Actionable Information Across Product Platforms
3. Obama Healthcare Reforms Fall Short, but Betterthanmedicare.com Closes the Donut Hole
4. Peregrine Pharmaceuticals Forms Anti-Viral Research Group to Oversee Its Anti-PS Infectious Disease Collaborations
5. American University of Beirut Medical Team Successfully Performs First Artificial Heart Implant in Lebanon
6. DSM Announces Yield Boosts of 5-10 Fold With XD(R) Technology for Mammalian Manufacturing Platforms
7. The Villa Group Informs on Mexico Travel Plans in Wake of Swine Flu Outbreak
8. Clinical Data Reinforce Safety and Efficacy of Boston Scientifics Two Drug- Eluting Stent Platforms
9. Fertility Physicians of Northern California Researchers Test New Forms of Progesterone Medication for Luteal Support During IVF
10. Huntington Hospital Surgeon Performs First Single Port Resection on Colorectal Cancer Patient in CA
11. Raptor Pharmaceuticals Provides Update on Targeting Platforms
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/29/2015)...  Epic Sciences announced today that the company will ... resistant prostate cancer patients, at the 2015 annual ... This application expands the investigational utility of Epic ... to characterize circulating tumor cell (CTC) genomic alterations. ... heterogeneous clonal CTC populations harboring separate genetic alterations. ...
(Date:5/28/2015)... Lilly and Company (NYSE: LLY ) announced today the ... up to $1.6 billion aggregate principal amount of certain of ... tendered, and did not validly withdraw, their notes on or ... time, on May 27, 2015 (the early tender date), and ... receive the total consideration. The total consideration for each series ...
(Date:5/28/2015)... May 28, 2015  Maetrics ( http://maetrics.com ), a ... sector, wrapped up a successful conference, "The cost of ... industry," today in Zurich . ... and its Switzerland -based team, experts ... Medical Technology field to an exclusive local audience. The ...
Breaking Medicine Technology:Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 2Genetic Analysis of Single Circulating Tumor Cells Shows High Intra-patient Heterogeneity 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 2Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 3Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 4Lilly Announces the Pricing Terms of Its Cash Tender Offer for Up to $1.6 Billion Aggregate Principal Amount of Its Outstanding Debt Securities 5Maetrics Hosts Innovative Medical Cluster Event in Switzerland 2
(Date:5/30/2015)... 2015 Wixom, Michigan: Proof. Pest Control, a family-owned ... a new twist to its robust line of services-a ... used for general pest management. , “We like ... Wixom Branch Manager. “The average person cringes when they see ... with problems that most people don’t even want to think ...
(Date:5/30/2015)... the Snail ” was featured on NewsWatch as part of ... and coolest applications on the market for iOS, Android, and ... conducted the app review and shared with viewers how this ... Interactive mobile games for children have become quite popular these ... playing are doing much for their intellectual development. However, there’s ...
(Date:5/29/2015)... 30, 2015 “In the current ... and federal regulations, we provide education that will ... who are suffering from pain, within the boundaries ... MD, professor of rehabilitation medicine and President/Medical Director ... Park, Kansas. , A new flight of PAINWeekEnd ...
(Date:5/29/2015)... May 29, 2015 M3 USA MDLinx.com, ... in 14 medical specialties, now offers The Smartest ... spectrum of rheumatology disorders ranging from Fibromyalgia and Osteoporosis, ... editorial director of MDLinx, and Caroline Tredway, editorial head ... impact it will have on the physicians who participate. ...
(Date:5/29/2015)... Angeles, CA (PRWEB) May 29, 2015 The ... greatly in the last decade. New and more efficient methods ... hair available to balding patients. One of the most cutting ... Parsa Mohebi Hair Restoration is the technique of extracting hair ... to scalp transplants are performed to correct male pattern ...
Breaking Medicine News(10 mins):Health News:Proof. Pest Control-Now Offering 100% Organic Pest Control in Southeast Michigan 2Health News:An Aesthetic Game that Engages and Educates Children was Featured on NewsWatch Television 2Health News:PAINWeekEnd Kansas City: Pain Management CME for the Main Street Practitioner 2Health News:MDLinx Launches Smartest Rheumatologist 2Health News:Beard to Scalp Hair Transplant: Newest Advance in Hair Transplant Technology 2
... , , PISCATAWAY, N.J., Aug. 10 ... today announced its second quarter financial results for the three and six months ended ... Three Months Ended June 30, 2009 with Three Months Ended June 30, 2008: ... to $2.04 million, up 32% from $1.55 million. , ...
... , PRINCETON, N.J., Aug. 10 Pharmasset, Inc. (Nasdaq: ... discovering, developing, and commercializing novel drugs to treat viral infections, today ... June 30, 2009. , , Financial ... during the quarter ended June 30, 2009 compared to $0.5 million ...
... SALT LAKE CITY, Aug. 10 ("WorldHeart", Nasdaq: WHRT ... today that it has appointed Morgan Brown as Executive Vice President ... experience to WorldHeart. , , Mr. Brown ... Officer and Senior Vice President since 2008. While at Lifetree Clinical ...
... SHENZHEN, China, Aug. 10 /PRNewswire-Asia-FirstCall/ -- Mindray Medical,International ... of medical devices worldwide announced today its selected unaudited,financial results for ... , Highlights for Second Quarter and First Half ... $160.1 million, an increase of, ...
... NASHVILLE, Tenn., Aug. 10 Healthcare Realty Trust Incorporated (NYSE: ... for the quarter ended June 30, 2009. This dividend, in ... 2009 to shareholders of record on August 21, 2009. , ... investment trust that integrates owning, managing and developing income-producing real estate ...
... WESTPORT, Conn., Aug. 10 FoodBizDaily.com, the leading news source for ... "International Trade Opportunity: The Brazilian Acai Berry." , , ... firm for the natural products industry, Americans spent more than $108 ... up from just over U.S.$62 million the year before. , ...
Cached Medicine News:Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 2Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 3Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 4Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 5Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 6Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 7Health News:Milestone Scientific Reports 44% Increase in Revenues in First Six Months of 2009 Compared to Prior Year 8Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 2Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 3Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 4Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 5Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 6Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 7Health News:Pharmasset Reports Fiscal Third Quarter 2009 Financial Results 8Health News:WorldHeart Appoints Morgan Brown as New Vice President of Finance and Chief Financial Officer 2Health News:Mindray Announces Second Quarter 2009 Financial Results 2Health News:Mindray Announces Second Quarter 2009 Financial Results 3Health News:Mindray Announces Second Quarter 2009 Financial Results 4Health News:Mindray Announces Second Quarter 2009 Financial Results 5Health News:Mindray Announces Second Quarter 2009 Financial Results 6Health News:Mindray Announces Second Quarter 2009 Financial Results 7Health News:Mindray Announces Second Quarter 2009 Financial Results 8Health News:Mindray Announces Second Quarter 2009 Financial Results 9Health News:Mindray Announces Second Quarter 2009 Financial Results 10Health News:Mindray Announces Second Quarter 2009 Financial Results 11Health News:Mindray Announces Second Quarter 2009 Financial Results 12Health News:Mindray Announces Second Quarter 2009 Financial Results 13Health News:Mindray Announces Second Quarter 2009 Financial Results 14Health News:Mindray Announces Second Quarter 2009 Financial Results 15Health News:Mindray Announces Second Quarter 2009 Financial Results 16Health News:Mindray Announces Second Quarter 2009 Financial Results 17Health News:Mindray Announces Second Quarter 2009 Financial Results 18Health News:FoodBizDaily.com Announces New Free Report - 'International Trade Opportunity: The Brazilian Acai Berry' 2
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
... of flexible lighting products. The first is ... different sizes 5", 10", and 15" (refers ... light). These lights are for use in ... ,The second group of flexible lights is ...
These units, though small, still offer sufficient output to ensure current is fully adjustable from 0 to 70 mA. Instruction manual, ball electrodes, battery and leads with alligator clips are include...
Designed to be used for neuromuscular blockage monitoring. Provides for easy placement over the ulnar nerve on a patient's wrist. Dual element permits non-invasive monitoring using a single electrode...
Medicine Products: